Has Rami Aboumourad, OD received payments from drug or device companies?

Yes. Drug and device makers reported $10,309 in general payments to Rami Aboumourad, OD across 42 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rami Aboumourad, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rami Aboumourad, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rami Aboumourad, OD

Optometrist · Miami, FLNPI 1275191066

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,206 of the $10,309 with a category attached, or 60.2%. Kedrion Biopharma, Inc. accounts for 62.4% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $7,435, more than ten times the $246 reported in 2019. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,309in general payments, 2019–2025

Across 42 payments — averaging $245.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kedrion Biopharma, Inc.$6K
Alcon$651
Bausch & Lomb Americas Inc.$608
Sun Pharmaceutical Industries Inc.$433
Bausch & Lomb, A Division Of Bausch Health US, LLC$362
Biotissue Holdings Inc.$279
plus $2K from 10 others

What the payments were for

Consulting fees$6,20660%
Food & beverage$4,10340%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kedrion Biopharma, Inc.	4	$6,435
Alcon	6	$651
Bausch & Lomb Americas Inc.	5	$608
Sun Pharmaceutical Industries Inc.	3	$433
Bausch & Lomb, A Division Of Bausch Health US, LLC	4	$362
Biotissue Holdings Inc.	3	$279
Rxsight Inc	2	$276
Dompe US, Inc.	2	$275
AbbVie(2 entities)	3	$232
Harrow Eye, LLC	2	$208
Johnson & Johnson Surgical Vision, Inc.	1	$144
Sight Sciences, Inc.	3	$142
Oyster Point Pharma, Inc.	1	$121
Astellas Pharma Global Development	1	$93
Carl Zeiss Meditec, Inc.	1	$33
Apellis Pharmaceuticals, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,309 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida →

Medicare billing

Part B allowed, 2024

$14,034

Medicare patients

165

Services billed

238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclosporine	12	$5,330
Prednisolone Acetate	17	$888
ValacyclovirValacyclovir Hcl	15	$528
Atropine Sulfate	11	$378
ErythromycinErythromycin Base	29	$301
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	18	$193
Latanoprost	14	$90
Azithromycin	15	$27

Paid to pharmacies, not to this prescriber.

Other optometrist in Miami

Mark DunbarMiami$236K
Elise KramerMiami$168K
Diana ShechtmanMiami$78K
Angelica CifuentesMiami$68K
Kristie DraskovicMiami$36K
Arnaldo CarmouzeMiami$25K
James HoffmanOrange Park$795K
April JasperWest Palm Beach$553K
Nora CothranLargo$505K
Michael SluskyNorth Port$384K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →